Active Ingredient: EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Proprietary Name: EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 400MG;300MG;300MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A213038
Product Number: 001
Approval Date: May 14, 2020
Applicant Holder Full Name: LAURUS LABS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information